Table 4 Antibiotic-potentiating activity of the isolated compounds.
CIP | ERY | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Lut | Apig | Chry | Gen | Daid | Lut | Apig | Chry | Gen | Daid | ||
M116 | MICa | 30 | >120 | >120 | >120 | >120 | 30 | >120 | >120 | >120 | >120 |
MICb | — | 30 | — | 60 | 15 | 3.5 | 30 | — | 30 | — | |
R | — | 4 | — | 4 | 2 | 2 | 4 | — | 4 | — | |
FICI | I | ≤0.38 (P) | I | ≤0.50 (P) | >0.5 (I) | 0.63 (I) | ≤0.38 (P) | I | ≤0.38 (P) | I | |
RWW337 | MICa | 30 | >120 | >120 | >120 | >120 | 30 | >120 | >120 | >120 | >120 |
MICb | — | 60 | — | 60 | — | — | 30 | — | 60 | — | |
R | — | 8 | — | 8 | — | — | ≥2 | — | ≥4 | — | |
FICI | I | ≤0.38 (P) | I | ≤0.38 (P) | I | I* | (*) | I* | ≤0.50 (P)* | I* | |
RWW50 | MICa | 60 | >120 | >120 | >120 | >120 | 30 | >120 | >120 | >120 | >120 |
MICb | — | 15 | — | 30 | — | — | — | — | 60 | — | |
R | — | 2 | — | 2 | — | — | — | — | 4 | — | |
FICI | I | >0.5 (I) | I | >0.5 (I) | I | I | I | I | ≤0.50 (P) | I | |
M82 | MICa | 120 | >120 | >120 | >120 | >120 | 60 | >120 | >120 | >120 | >120 |
MICb | 60 | 30 | — | 30 | — | 60 | — | — | 30 | — | |
R | 4 | 2 | — | 2 | — | 4 | — | — | 2 | — | |
FICI | 0.75 (I) | >0.5 (I) | I | >0.5 (I) | I | 0.75 (I) | I | I | >0.5 (I) | I | |
RN6390 | MICa | 120 | >120 | >120 | >120 | >120 | 120 | >120 | >120 | >120 | >120 |
MICb | — | — | — | — | — | — | — | — | — | — | |
R | — | — | — | — | — | — | — | — | — | — | |
FICI | I | I | I | I | I | I | I | I | I | I | |
CECT 976 | MICa | 120 | >120 | >120 | >120 | >120 | 120 | >120 | >120 | >120 | >120 |
MICb | — | — | — | 30 | 30 | — | — | — | 30 | — | |
R | — | — | — | 4 | 2 | — | — | — | 4 | — | |
FICI | I | I | I | ≤0.38 (P) | >0.5 (I) | I | I | I | ≤0.38 (P) | I | |
SA1199B | MICa | 120 | >120 | >120 | >120 | >120 | n.p. | ||||
MICb | — | 10 | — | 60 | 60 | ||||||
R | — | 2 | — | 8 | 4 | ||||||
FICI | I | >0.5 (I) | I | ≤0.38 (P) | ≤0.25 (P) |